1Monk BJ, Choi DC, Pugmire G, et al. Activity of bevacizumab (rhuMAB VEGF)in advanced refractory epithelial ovarian cancer [ J ]. Gynecol Oncol, 2005,96 : 902 - 905.
2Aghajanian C. The role of bevacizumab in ovarian cancer - An evolving story[J]. Gynecol Oncol, 2006,102(2) :131 - 133.
3Burger RA, Sill MW, Monk BJ, et al. Phase Ⅱ trial of bevaeizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer:a Gynecologic Oncology Group Study[J ]. J Clin Oncol,2007,25(33) :5165 - 5171.
